BMJ  2008;336:913 (26 April), doi:10.1136/bmj.39556.698646.DB

News

Most cases of research misconduct go undetected, conference told

¹ London

Questionable research practices are common and probably do more damage to science than the "big three" of fabrication, falsification, and plagiarism, said Nick Steneck, consultant to the US Office of Research Integrity, last week at a conference on the governance of good research conduct in the United Kingdom.

The priority in the United States had been to eliminate serious research misconduct, said Professor Steneck, but now much more attention is being paid to preventing "questionable research practices," which take many forms, including poor design, incomplete literature review, failure to report some evidence, unreported outcomes, failure to declare conflicts of interest, and redundant publication.

Later in the conference, Onora O’Neill, president of the British Academy, said that she regarded poor research and research that wasn’t needed or was poor value for money as being a matter of research integrity.

Ian Kennedy, chairman of the UK Panel for Research Integrity in Health . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Rapid Responses:

Read all Rapid Responses

fraud in clinical trials

Nicholas D Moore
bmj.com, 25 Apr 2008 [Full text]